Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. (10th July 2019)
- Record Type:
- Journal Article
- Title:
- Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. (10th July 2019)
- Main Title:
- Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
- Authors:
- Zhai, Jing
Shen, Jiajia
Xie, Guiping
Wu, Jiaqi
He, Mingfang
Gao, Lili
Zhang, Yifen
Yao, Xuequan
Shen, Lizong - Abstract:
- Abstract: Chemoresistance remains the major obstacle to achieve optimal prognosis in gastric cancer patients, and the underlying molecular mechanisms of cancer-associated fibroblasts (CAFs) in gastric cancer chemoresistance remain poorly understood. We identified the high pretherapeutical serum IL-8 level in gastric cancer patients was associated with poor response to platinum-based therapy, and it increased gradually during neoadjuvant chemotherapy and it decreased after radical surgery. Immunohistochemistry assays showed that IL-8 was highly expressed in gastric cancer tissues in chemoresistant patients, and located in CAFs. Primary CAFs produced more IL-8 than the corresponding normal fibroblasts, and human stomach fibroblast line Hs738 secreted more IL-8 after co-cultured with conditioned media from AGS or MGC-803 cells. IL-8 increased the IC50 of cisplatin (CDDP) in AGS or MGC-803 in vitro . Simultaneously, IL-8 treatment enhanced the expression of PI3K, phosphorylated-AKT (p-AKT), phosphorylated-IKb (p-IKb), phosphorylated-p65 (p-p65) and ABCB1, and ABCB1 and p-p65 were overexpressed in tumor tissues of chemoresistant patients. Collectively, CAFs derived IL-8 promotes chemoresistance in human gastric cancer via NF-κB activation and ABCB1 up-regulation. Our study provides a novel strategy to improve the chemotherapeutical efficacy and the prognosis of gastric cancer. Graphical abstract: Image 1 Highlights: The high serum IL-8 level was related to poor response toAbstract: Chemoresistance remains the major obstacle to achieve optimal prognosis in gastric cancer patients, and the underlying molecular mechanisms of cancer-associated fibroblasts (CAFs) in gastric cancer chemoresistance remain poorly understood. We identified the high pretherapeutical serum IL-8 level in gastric cancer patients was associated with poor response to platinum-based therapy, and it increased gradually during neoadjuvant chemotherapy and it decreased after radical surgery. Immunohistochemistry assays showed that IL-8 was highly expressed in gastric cancer tissues in chemoresistant patients, and located in CAFs. Primary CAFs produced more IL-8 than the corresponding normal fibroblasts, and human stomach fibroblast line Hs738 secreted more IL-8 after co-cultured with conditioned media from AGS or MGC-803 cells. IL-8 increased the IC50 of cisplatin (CDDP) in AGS or MGC-803 in vitro . Simultaneously, IL-8 treatment enhanced the expression of PI3K, phosphorylated-AKT (p-AKT), phosphorylated-IKb (p-IKb), phosphorylated-p65 (p-p65) and ABCB1, and ABCB1 and p-p65 were overexpressed in tumor tissues of chemoresistant patients. Collectively, CAFs derived IL-8 promotes chemoresistance in human gastric cancer via NF-κB activation and ABCB1 up-regulation. Our study provides a novel strategy to improve the chemotherapeutical efficacy and the prognosis of gastric cancer. Graphical abstract: Image 1 Highlights: The high serum IL-8 level was related to poor response to platinum-based therapy. IL-8 was highly expressed in cancer-associated fibroblast in chemoresistant patient. IL-8 increased the IC50 of cisplatin in AGS or MGC-803 in vitro . IL-8 treatment enhanced the expression of p-AKT, p-IKb, p-p65 and ABCB1. ABCB1 and p-p65 were overexpressed in tumor tissues of chemoresistant patients. … (more)
- Is Part Of:
- Cancer letters. Volume 454(2019)
- Journal:
- Cancer letters
- Issue:
- Volume 454(2019)
- Issue Display:
- Volume 454, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 454
- Issue:
- 2019
- Issue Sort Value:
- 2019-0454-2019-0000
- Page Start:
- 37
- Page End:
- 43
- Publication Date:
- 2019-07-10
- Subjects:
- Chemoresistance -- Cancer-associated fibroblast -- IL-8 -- NF-κB -- ABCB1
NAC neoadjuvant chemotherapy -- POAC postoperative adjuvant chemotherapy -- POC perioperative chemotherapy -- ECF epirubicin/cisplatin/infusional 5-FU -- FLOT docetaxel/oxaliplatin/5-fluorouracil -- GEJ gastroesophageal junction -- TME tumor microenvironment -- CAFs Cancer-associated fibroblasts -- CT computed tomography -- EUS endoscopic ultrasonography -- RECIST response evaluation criteria in solid tumors -- NFs normal fibroblasts -- ELISA enzyme-linked immunosorbent assay -- CCK-8 cell counting kit-8 -- α-SMA α-smooth muscle actin -- IHC immunohistochemistry -- CDDP cisplatin -- ABCB1 ATP-binding cassette subfamily B member 1 -- NF-κB nuclear factor kappa B -- ECM extracellular matrix -- MSCs mesenchymal stem cells -- FSP-1 fibroblast-specific protein-1 -- FAP fibroblast-activated protein -- TEM1 tumor endothelial marker 1
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2019.04.002 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10135.xml